GC Wellbeing said on the 7th that it signed a contract to export the skin booster "Giselle Ribonne" to Japan. It is made into human acellular dermal matrix (hADM) by removing cells that trigger immune responses from human skin tissue and leaving the remaining components.
GC Wellbeing signed a supply agreement for Giselle Ribonne with its Japanese partner, Nifuji. The company said it plans to conduct academic marketing for Japanese medical professionals next month.
The company will proceed with the domestic launch in parallel with entry into the Japanese market. It set a goal of expanding overseas using Japan—where the skin booster industry is growing steadily—as a base. It plans to promote the product focusing on local partners and technology.
A GC Wellbeing official said, "We have experience succeeding with Laennec, made from human placenta," adding, "Based on acellular dermal matrix technology, we will expand our presence in the Asian market."